ATR and Alzheimer disease: Three of the genes, CALN1, ATR and OGDH are most likely to serve as biomarkers or targets in AD, although further research is needed on these hub genes to explore their specific roles and potential underlying mechanisms in AD, our findings provide potential biomarkers and targets that lead to better prevention and treatment of AD in the future.